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Previewsit is intriguing that non-kap HEAT proteins
also utilize flexibility in order to translocate
efficiently through the pore.
In order to establish that HEAT pro-
teins indeed act as transport factors
in vivo, some important open questions
need to be addressed in future
studies. In the current study, transloca-
tion assays were conducted in both
digitonin-permeabilized cells and live
cells using fluorescence recovery after
photobleaching analysis with some-
what different results in each assay.
This is not surprising, considering the
complexity of the protein interaction
network in living cells and the likely fierce
competition for FG binding sites within
the cellular milieu (Jovanovic-Talisman
et al., 2009; Andersen et al., 2013). For
instance, the authors showed that pro-
tein phosphatase 2A (PP2A) subunit A
mediates the transport of the entire
trimeric PP2A complex in vitro and
possibly in vivo. PP2A was previously
shown to interact with two members of
the Kap-b family (Lubert and Sarge,
2003), and Yoshimura et al. (2014)
knocked down one of them in order to
control for Kap-mediated import. How-
ever, considering the large number of
different Kap-b proteins within mamma-
lian cells, some of which are essential,1694 Structure 22, December 2, 2014 ª2014it is not simple to fully establish that
in vivo translocation is completely inde-
pendent of Kaps. Another possibility is
that by interacting with the pore, HEAT
proteins like PP2A may support impor-
tins in transporting large complexes, as
may be evidenced by the gradual
decrease in transport rates upon knock-
down of importin 7 reported in this study.
This would also prevent the large cellular
concentrations of importin b from out-
competing PP2A.
If HEAT proteins indeed use their
kinship to nuclear transport receptors to
translocate through nuclear pores, the
next step would be to identify those re-
peats within HEAT proteins that mediate
interactions with the nuclear pore and
characterize the evolutionary constraints
for adapting existing HEAT repeat do-
mains for gain of access to the nucleus.
We could even speculate that the first
HEAT repeat domains mediated their
own translocation before some of them
coevolved with cargo proteins to become
specialized nuclear transport receptors of
the Kap family.ACKNOWLEDGMENTS
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C-type lectin-like receptor 2 (CLEC-2) is a member of the C-type lectin (like) receptor (CLR) family that uses a
Ca2+ binding domain to bind specific glycans. However, in this issue of Structure, Nagae and colleagues
report on how the structures of CLEC-2 in complex with a glycopeptide podoplanin and a snake venom pro-
tein, rhodocytin, show a different mode of binding.Cell surface receptors play a critical role in
mediating cell-cell interactions and regu-
lating numerous physiological events.
They are also targeted by microbes thathijack them during the infection process.
In turn, the host cells use their cell surface
receptors as the front line defense to
recognize and eliminate infectious micro-organisms. Immune cell surface recep-
tors are largely comprised of immuno-
globulin (Ig) and C-type lectin (like)
receptor (CLR) families (Kuroki et al.,
Figure 1. Comparison of Ligand Recognition Modes of CLRs and Other Cell Surface Receptors
Overview of complexes. Rainbow coloring is shown in CLRs. Stick models represent glycan (yellow) and peptides (magenta). Ca ions are shown as green balls
in (A). E-cadherin (B) and rhodocytin (D) are shown in catoon models (magenta).
(A) P-selectin-PSGL-1.
(B) KLRG1-E-cadherin.
(C) CLEC-2-podoplanin.
(D) CLEC-2-rhodocytin.
Simultaneous recognition sites to O-glycan and peptides. Proteins are shown as white models. The coloring of glycopeptides is the same as in (A)–(D). Sulfate is
shown in cyan (F).
(E) CLEC-2-podoplanin.
(F) P-selectin-PSGL-1.
(G) PILRa-HSV1 gB.
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Previews2012). These structural frames seem to
be beneficial for detecting various types
of ligands. Notably, in Ig domains, almost
the entire surface is available for ligand
recognition, while CLR domains utilize
conventional Ca2+ binding site, regard-
less of whether ligands are sugars or
proteins (Figures 1A and 1B) (Li and
Mariuzza, 2014; Taylor and Drickamer,
2009). However, in this issue of Structure,
Nagae et al. (2014) report that a C-type
lectin-like domain can utilize the noncon-
ventional site for sugar recognition,
distinct from Ca2+ binding site generally
responsible for sugar binding in CLRs.
This nonconventional ligand binding site
is revealed in the crystal structure of C-
type lectin-like receptor 2 (CLEC-2) com-
plexes with the O-linked sugar site of
podoplanin (Figure 1C). From the struc-
ture, it can be seen that CLEC-2 is well
adapted for binding to the sugar part ofglycopeptide region in podolanin while
losing the Ca2+ ion mediation. Further-
more, CLEC-2 exhibits positively charged
residues for specific recognition of
the peptide part of the glycopeptide, the
‘‘Glu-Asp’’ motif (Figure 1E). In this case,
the combination of sugar recognition
with other binding regions confers the
specificity. This work adds another inter-
esting example to the growing under-
standing of glycopeptide binding lectins.
Previous examples that are worth noting
include P-selectin, which belongs to
CLR and recognizes both sugar and
sulfated tyrosine of PSGL-1 in the con-
ventional site (Figure 1F) (Somers et al.,
2000), and the member of the Siglec
(sialic acid binding Ig-type lectins) family,
PILRa, which binds to glycopeptide
of mucin-like families, which also use
two sites, the sialic acid binding site
(conserved in Siglec family) and the pep-Structure 22, December 2, 2014tide binding surface (Figure 1G) (Kuroki
et al., 2014). As depicted in Figures
1E–G, the binding modes in these sys-
tems are variable, but all include regions
facing toward sugar and peptide parts.
It is interesting to note that, in addition
to glycopeptide-binding receptors, other
members of CLRs like Mincle and
MCL exhibit glycolipid recognition. These
CLRs use the conventional Ca2+ binding
site for sugar recognition and a neigh-
boring hydrophobic region in lipid recog-
nition (Feinberg et al., 2013; Furukawa
et al., 2013).
The CLEC-2-podoplanin interaction
is involved in important physiological
events, including the control of fibro-
blastic reticular network tension, lymph
node expansion, platelet aggregation,
and tumor metastasis. On the other
hand, snake venom toxin from the
Malayan pit viper, rhodocytin, inducesª2014 Elsevier Ltd All rights reserved 1695
Structure
Previewsthe CLEC-2-mediated platelet activation.
Nagae et al. (2014) also determined the
crystal structure of the CLEC-2/rhodocy-
tin complex (Figure 1D). Interestingly, the
binding site of rhodocytin, a purely pro-
tein-protein interaction, on CLEC-2 over-
laps with that of podoplanin and utilizes
the conserved ‘‘Glu-Asp’’ motif. This
shows that the site for binding both
endogeonous and exogenous ligands is
conserved, suggesting a possibility that
the most advanced venomous snakes
have evolved toxins to target the binding
sites of conserved physiological ligands
as an effective strategy to capture and
digest the prey and prevail over the natu-
ral enemies.
CLRs often exist as dimers, which are
believed to be important for effective
signaling. For instance, some CLRs,
such as NKG2s, KACL, and Ly49s, utilize
a2 and b1’ site for dimerization and
recognize the ligands using the con-
ventional Ca2+-mediated sugar binding
site without the Ca2+ ion. However,
as mentioned, the classical region
corresponding to the Ca2+-mediated
sugar binding site of CLEC-2 is not
involved in ligand binding; rather, it is
diverted to mediating the dimerization.
Subsequently, in the context of this
unique dimer architecture, the ligand
binding site of CLEC-2 is exposed to
the cell surface and faces outward,1696 Structure 22, December 2, 2014 ª2014where it can be easily accessed by the
ligands.
As described above, the CLEC-2-
podoplanin interaction leads to platelet
aggregation and is involved in tumor
metastasis. Kato et al. recently esta-
blished novel antibodies for aberrantly
glycosylated podoplanin, which is
specifically expressed on tumor cells
(Kato and Kaneko, 2014). These anti-
bodies represent an advancement over
the well-characterized NZ-1 antibody,
which, although it can block the CLEC-
2-podoplanin interaction, also binds
to normal podoplanin-expressing cells.
Thus, such anti-podoplanin antibodies
that block the CLEC-2-podoplanin bind-
ing might be candidates for targeted
drug development to suppress tumor
metastasis. On the other hand, it is also
interesting to compare how CLEC-2
and antibodies recognize O-glycosylated
peptides and map out a detailed under-
standing of differences and similarities
between them.
Finally, the new face of the C-type lec-
tin-like domain of CLEC-2 for ligand bind-
ing clearly opens the possibility that CLRs
can utilize all surfaces as potential sites
for unidentified endogenous and exoge-
nous ligands, including those produced
by microorganisms, and employ different
dimer conformations in order to adjust
effective signaling.Elsevier Ltd All rights reservedACKNOWLEDGMENTS
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With a major leap in a long running saga, Jilkova and colleagues, in this issue of Structure, provide structural
and biochemical evidence for a role of sulfated polysaccharides in the activation of parasite digestive
proteases.Schistosomiasis (also known as bilharzia)
caused by parasitic worms of the genus
Schistosoma is endemic in over 70tropical/subtropical countries and infects
more than 200 million people, killing be-
tween 20,000 and 280,000 per annum(Lustigman et al., 2012). The infective
stage of Schistosoma mansoni, the most
common human schistosome, penetrates
